Up-regulation of PTTG1 has been correlated with aggressive disease and poor prognosis in hepatocellular carcinoma, prostate cancer, esophageal cancer, glioma, thyroid cancer and colorectal cancer [13–19]. Here, PTTG1 is linked to colorectal cancer.